Proliferation in response to physiological concentrations of E2 has been reported in cultured ovarian cancer cells expressing ER, but currently there is no direct evidence in support of the hypothesis that high E2 levels present within the microenvironment of the ovary following ovulation contribute to the induction of ovarian cancer. Here, ESR1 is linked to ovarian carcinoma.